The EU aspires to utilize the economic advantages of gene-editing technology on one hand and ensure human health and environmental safety on the other. Surrounding the fierce debates over emerging gene-edited plant, the current debate focused on the issue of whether the gene-edited crop should be within or outside the GMO law and its implication for innovation. It should not be forgotten that it is also involved in the complex patentability issues pertaining to the legal interpretation of the patent law. The gene-edited crop is governed by GMO regulations due to its potential risk to human health and environmental safety. But it is heavily patented, as patent regulations ignore its potential risk. This article examines the discrepancy of the gene-edited crop between the existing GMO law and the patent law and reveals the challenges to current EU jurisdiction, including the international trade impediment challenge, the patent monopoly challenge, the market confusion challenge, and the agricultural economy suspension challenge. In the end, this article argues that EU GMO regulations should be bridged with a patent system in facing the regulatory challenges from the gene-edited crop.

中文翻译：

---

基因编辑作物的商业化与道德：来自欧盟自由专利法和严格转基因法的挑战

欧盟一方面渴望利用基因编辑技术的经济优势，另一方面确保人类健康和环境安全。围绕新兴基因编辑植物的激烈争论，当前的争论集中在基因编辑作物是否应该在转基因法律之内或之外的问题及其对创新的影响。不应忘记，它还涉及与专利法的法律解释有关的复杂的可专利性问题。由于基因编辑作物对人类健康和环境安全存在潜在风险，因此受转基因法规管辖。但它获得了大量专利，因为专利法规忽视了其潜在风险。本文考察了现有转基因法与专利法之间基因编辑作物的差异，揭示了当前欧盟管辖权面临的挑战，包括国际贸易障碍挑战、专利垄断挑战、市场混乱挑战和农业经济暂停挑战。最后，本文认为欧盟 GMO 法规应与专利制度联系起来，以应对基因编辑作物的监管挑战。